Parents’ Decisions About HPV Vaccine for Sons: The Importance of Protecting Sons’ Future Female Partners

Journal of Community Health

Volumn 39, Issue 5, 2014, Pages 842-848

  Schuler, Christine L ^a   DeSousa, Nancy S ^b   Coyne Beasley, Tamera ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent; Human papillomavirus vaccines; Male; Parents; Sexual partners

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; CHILD; DECISION MAKING; FEMALE; HUMAN; MALE; PAPILLOMAVIRUS INFECTIONS; PARENT; PSYCHOLOGY; SEX DIFFERENCE; SEXUALITY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DECISION MAKING; FEMALE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; SEX FACTORS; SEXUAL PARTNERS; YOUNG ADULT;

EID: 84918836391     PISSN: 00945145     EISSN: 15733610     Source Type: Journal    
DOI: 10.1007/s10900-014-9859-1     Document Type: Article

References (26)

1. Lacey, C. J., Lowndes, C. M., & Shah, K. V. (2006). Chapter 4: Burden and management of non-cancerous HPV-related conditions. HPV-6/11 disease. Vaccine, 24(Suppl 3), S3/35–41. doi:10.1016/j.vaccine.2006.06.015.
2. Parkin, D. M., & Bray, F. (2006). Chapter 2: The burden of HPV-related cancers. Vaccine, 24(Suppl 3), S3/11–25. doi:10.1016/j.vaccine.2006.05.111.
3. Munoz, N., Castellsague, X., de Gonzalez, A. B., & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24(Suppl 3), S3/1–10. doi:10.1016/j.vaccine.2006.05.115.
4. Miralles-Guri, C., Bruni, L., Cubilla, A. L., Castellsague, X., Bosch, F. X., & de Sanjose, S. (2009). Human papillomavirus prevalence and type distribution in penile carcinoma. Journal of Clinical Pathology,62(10), 870–878. doi:10.1136/jcp.2008.063149.
5. Daling, J. R., Madeleine, M. M., Johnson, L. G., et al. (2004). Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer,101(2), 270–280. doi:10.1002/cncr.20365.
6. Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiology Biomarkers Prevention,14(2), 467–475. doi:10.1158/1055-9965.EPI-04-0551.
7. Markowitz, L. E., Dunne, E. F., & Saraiya, M., et al. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendation Reports, 56(RR-2), 1–24.
8. Prevention Centers for Disease C. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. Morbidity and Mortality Weekly Report,59(20), 630–632.
9. Prevention Centers for Disease C. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. Morbidity and Mortality Weekly Report,60(50), 1705–1708.
10. Prevention Centers for Disease C. (2013). National and state vaccination coverage among adolescents aged 13–17 years—United States, 2012. MMWR. Morbidity and Mortality Weekly Report,62(34), 685–693.
11. Reiter, P. L., Pendergraft, W. F, 3rd, & Brewer, N. T. (2010). Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiology Biomarkers Prevention,19(11), 2916–2931. doi:10.1158/1055-9965.EPI-10-0576.
12. Dempsey, A. F., Butchart, A., Singer, D., Clark, S., & Davis, M. (2011). Factors associated with parental intentions for male human papillomavirus vaccination: Results of a national survey. Sexually Transmitted Diseases,38(8), 769–776. doi:10.1097/OLQ.0b013e318211c248.
13. Olshen, E., Woods, E. R., Austin, S. B., Luskin, M., & Bauchner, H. (2005). Parental acceptance of the human papillomavirus vaccine. Journal of Adolescent Health,37(3), 248–251. doi:10.1016/j.jadohealth.2005.05.016.
14. Watts, L. A., Joseph, N., Wallace, M., et al. (2009). HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecologic Oncology,112(3), 577–582. doi:10.1016/j.ygyno.2008.12.010.
15. Reiter, P. L., McRee, A. L., Gottlieb, S. L., & Brewer, N. T. (2010). HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure. Vaccine,28(38), 6292–6297. doi:10.1016/j.vaccine.2010.06.114.
16. Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health Education Quarterly,11(1), 1–47.
17. Rothman, S. M., & Rothman, D. J. (2009). Marketing HPV vaccine: Implications for adolescent health and medical professionalism. JAMA,302(7), 781–786. doi:10.1001/jama.2009.1179.
18. Reiter, P. L., Oldach, B. R., Randle, K. E., & Katz, M. L. (2014). Acceptability of HPV vaccine for males and preferences for future education programs among appalachian residents. American Journal of Mens Health,8(2), 167–174. doi:10.1177/1557988313505319.
19. Cates, J. R., Ortiz, R., Shafer, A., Romocki, L. S., & Coyne-Beasley, T. (2012). Designing messages to motivate parents to get their preteenage sons vaccinated against human papillomavirus. Perspective Sexual Reproductive Health,44(1), 39–47. doi:10.1363/4403912.
20. Liddon, N., Hood, J., Wynn, B. A., & Markowitz, L. E. (2010). Acceptability of human papillomavirus vaccine for males: A review of the literature. Journal of Adolescent Health,46(2), 113–123. doi:10.1016/j.jadohealth.2009.11.199.
21. Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine,45(2–3), 107–114. doi:10.1016/j.ypmed.2007.05.013.
22. Alexander, A. B., Stupiansky, N. W., Ott, M. A., Herbenick, D., Reece, M., Zimet G. D. Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr, 12, 192. doi:10.1186/1471-2431-12-192.
23. Gerend, M. A., & Barley, J. (2009). Human papillomavirus vaccine acceptability among young adult men. Sexually Transmitted Diseases,36(1), 58–62. doi:10.1097/OLQ.0b013e31818606fc.
24. DiClemente, R. J., Crosby, R. A., Salazar, L. F., Nash, R., & Younge, S. (2011). Is male intent to be vaccinated against HPV a function of the promotion message? International Journal of STD and AIDS,22(6), 332–334. doi:10.1258/ijsa.2011.010429.
25. Reiter, P. L., McRee, A. L., Pepper, J. K., Gilkey, M. B., Galbraith, K. V., & Brewer, N. T. (2013). Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. American Journal of Public Health,103(8), 1419–1427. doi:10.2105/AJPH.2012.301189.
26. Elbasha, E. H., & Dasbach, E. J. (2010). Impact of vaccinating boys and men against HPV in the United States. Vaccine,28(42), 6858–6867. doi:10.1016/j.vaccine.2010.08.030.